Aptevo Therapeutics Inc.·4

Jun 2, 4:39 PM ET

Kwon SoYoung 4

4 · Aptevo Therapeutics Inc. · Filed Jun 2, 2023

Insider Transaction Report

Form 4
Period: 2023-05-31
Kwon SoYoung
SVP, GC, BD & Corp Affairs
Transactions
  • Exercise/Conversion

    Common Stock

    2023-05-31+1,8347,333 total
  • Exercise/Conversion

    Restricted Stock Unit

    2023-05-311,8341,833 total
    Common Stock (1,834 underlying)
Footnotes (2)
  • [F1]Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
  • [F2]On June 1, 2021, the reporting person was granted 5,500 RSUs, vesting in three approximately equal annual installments beginning on May 31, 2022.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION